Evidence map›Paper›PMID 33993983›Full record

ArticleCells & development2021

FoxL1

Ayano Kondo, Klaus H Kaestner

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells & development, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. NADNature communications · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ayano KondoDepartment of Genetics and Institute for Diabetes, Obesity and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: kondo@pennmedicine.upenn.edu.
Klaus H KaestnerDepartment of Genetics and Institute for Diabetes, Obesity and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: kaestner@pennmedicine.upenn.edu.
University of Pennsylvania · US

Funding

TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI JONATHAN P KATZ · 1997 to 2026
$32.5M
REGULATORY CASCADES IN GASTROINTESTINAL PROLIFERATIONR01DK053839 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KAESTNER, KLAUS H · 1998 to 2011
$4.5M
Regulatory cascades in gastrointestinal proliferationR37DK053839 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KAESTNER, KLAUS H · 2012 to 2021
$3.8M
Elucidating the regulation and function of FoxL1+ cell-derived Wnt5a during intestinal developmentF31DK125008 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KONDO, AYANO · 2020 to 2021
$52k
NIDDK NIH HHS F31 DK125008NIDDK NIH HHS P30 DK050306NIDDK NIH HHS R01 DK053839NIDDK NIH HHS R37 DK053839
6 · The paper itself

Abstract

Wnt5a is a non-canonical Wnt ligand that is essential for normal embryonic development in mammals. The role of Wnt5a in early intestinal development has been examined in gene ablation models, where Wnt5a

Indexed as

Embryonic DevelopmentAnimalsApoptosisCell PolarityCell ProliferationEpithelial CellsForkhead Transcription FactorsIntegrasesIntestinesMesodermMiceWnt-5a ProteinCre recombinaseForkhead Transcription FactorsFoxl1 protein, mouseIntegrasesWnt-5a ProteinFoxL1Intestinal developmentIntestinal mesenchymeMidgut elongationNon-canonical WntWnt5a

Identifiers

PMID33993983
PMCPMC7988427
OpenAlexW3127414175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.